Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001052645 | SCV001216866 | pathogenic | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg942*) in the ELP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ELP1 are known to be pathogenic (PMID: 18303054, 24173031). This variant is present in population databases (rs761911009, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 848810). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV004031649 | SCV002754963 | pathogenic | not specified | 2019-09-17 | criteria provided, single submitter | clinical testing | The p.R942* pathogenic mutation (also known as c.2824C>T), located in coding exon 25 of the IKBKAP gene, results from a C to T substitution at nucleotide position 2824. This changes the amino acid from an arginine to a stop codon within coding exon 25. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Fulgent Genetics, |
RCV002505601 | SCV002795884 | likely pathogenic | Medulloblastoma; Familial dysautonomia | 2021-12-20 | criteria provided, single submitter | clinical testing | |
St. |
RCV003444766 | SCV004171533 | pathogenic | Medulloblastoma | 2023-10-16 | criteria provided, single submitter | clinical testing | The ELP1 c.2824C>T (p.Arg942Ter) change is a nonsense variant that is predicted to cause premature protein truncation or absence of protein due to nonsense-mediated decay. This variant has been reported in an individual with the sonic hedgehog (SHH) subtype of medulloblastoma (internal data). This variant has a maximum subpopulation frequency of 0.01% in gnomAD v2.1.1 (https:// gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as pathogenic. |